Top Markets
#1 MON MON +2,760.08%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +52.36%
#4 eCash eCash +37.30%
#5 Siren Siren +24.28%
#6 Collector Crypt Collector Crypt +23.96%
#7 PinGo PinGo +23.93%
#8 SAFEcoin SAFEcoin +19.72%
#9 Janction Janction +19.66%
#10 Beldex Beldex +15.26%
Coin of the day
MON MON
Settings
Language
ENGLISH
Currency
USD
Theme
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Rank in Stocks #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Share Price
$0.30840035
Market Cap
$94.37M
Change (1 day)
0.00%
Change (1 year)
-34.60%
Country
FR
Trade Sensorion SA (ALSEN)

Category

Healthcare
Stock price history for Sensorion SA (ALSEN)
Highest end of day price: $0.30 on 2026-07-01

Lowest end of day price: $4.88 on 2015-04-01
Stock price history of Sensorion SA from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -14.19%
2025 -35.43%
2024 42.20%
2023 21.00%
2022 -80.41%
2021 12.23%
2020 121.36%
2019 -30.56%
2018 -66.86%
2017 -29.31%
2016 -42.01%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $49.48 -28.22%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $478.51 2.06%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $658.80 16.04%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $280.05 40.43%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $868.37 55.00%
NL